VICENTE
ESTRADA PÉREZ

Profesor titular de universidad

Foto de VICENTE

Foto de Orlando Immunology Center

Orlando Immunology Center

Orlando, Estados Unidos

Publicaciones en colaboración con investigadores/as de Orlando Immunology Center (3)

2018

Tenofovir alafenamide plus emtricitabine versus abacavir plus lamivudine for treatment of virologically suppressed HIV-1-infected adults: a randomised, double-blind, active-controlled, non-inferiority phase 3 trial
The Lancet HIV, Vol. 5, Núm. 4, pp. e162-e171

2006

Concomitant use of an active boosted protease inhibitor with enfuvirtide in treatment - Experienced, HIV-infected individuals: Recent data and consensus recommendations
HIV Clinical Trials, Vol. 7, Núm. 2, pp. 86-96
The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial
Lancet, Vol. 368, Núm. 9534, pp. 476-482